Animal health conference shines spotlight on anthelmintic resistance
The AHDA Annual Conference is returning after a break of three years.
The Animal Health Distributor's Association's (AHDA) annual conference is set to shine a spotlight on the challenges of anthelmintic resistance.
From a closer look at the prescribing process to animal medicines planning, key issues facing the farming industry will be discussed at the 2023 event, allowing delegates access to the most up-to-date research and findings from industry experts.
The two-day gathering, initially postponed for two years owing to COVID-19 and again due to Her Majesty the Queen's funeral in September, will also cover topics related to the management of equine and companion animals.
Among the speakers include John Millward, head of inspections and enforcement at the Veterinary Medicines Directorate (VMD), Dave Bartely from the Moredun Research Institute and Jonathan Statham of the Animal Health and Welfare Board for England.
There will also be an exhibition attended by some 50 leading animal health companies, veterinary medicine manufacturers and industry groups, and an evening gala dinner.
The conference forms part of a broader AHDA campaign to enhance the responsible prescribing process of POM-VPS animal medicines products, focussing on anthelmintic resistance.
Bryan Lovegrove, AHDA secretary general, said: “In raising awareness of the challenges of anthelmintic resistance, and by focussing on it in detail at our conference, we hope to bring some of these areas of focus to life, encouraging conversation and engagement among those directly involved in the prescribing process in order to help the end users – their customers - better understand the topic.”
“We’re really looking forward to coming back together after a lengthy break. Exhibitor spaces have sold out, which is a clear indicator of the enthusiasm within the sector and the importance of meeting in-person to share ideas and discuss challenges."
The rescheduled event takes place Monday 23-Tuesday 24 January 2023. Further details are available at ahda.co.uk
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
